John Poulos
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
John Poulos currently works at Faron Pharmaceuticals Oy, as Independent Non-Executive Director from 2017, Memgen, Inc., as Director from 2020, and GNK Advisors, Inc., as President from 2016.
Mr. Poulos also formerly worked at Abbott Pharmaceutical, Inc., as Head-Pharmaceutical Licensing & Acquisitions from 2005 to 2012 and AbbVie Oy, as VP, Head-Business Development & Acquisitions from 2013 to 2016.
Mr. Poulos received his undergraduate degree and Masters Business Admin degree from Indiana University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| FARON PHARMACEUTICALS OY | Direktor/Vorstandsmitglied | 16.05.2017 |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Direktor/Vorstandsmitglied | 18.11.2020 |
GNK Advisors, Inc. | Präsident | 01.01.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Corporate Officer/Principal | 01.01.2016 |
Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | 01.01.2012 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures immuno-oncology drugs | Health Technology |
Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
GNK Advisors, Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen